Evaluating the effectiveness of vaccines for flu and COVID-19 against acute illnesses in Texas.
Official title: RFA-IP-22-004, Component A _ Credible Effectiveness Measures of Seasonal Influenza, COVID-19 and Other Respiratory Virus Vaccines against Ambulatory Care for Acute Illness in Texas (and Component D).
Funded at Baylor Research Institute · NIH-10910859 · Data updated 2026-11-12
This study is looking at how well the flu and COVID-19 vaccines help keep people in Central Texas from getting sick enough to need a doctor's visit, so we can better understand their effectiveness over time.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor Research Institute NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project start | September 30, 2022 |
| Project end | September 29, 2025 |
| Funding year | 2024 |
| Award (this year) | $1,400,000 |
| NIH project number | 5U01IP001189-03 |
| Project ID | NIH-10910859 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals in Central Texas who are eligible for seasonal flu and COVID-19 vaccinations.
✕Less likely to help
Patients who are not eligible for these vaccines or who do not reside in the study area may not benefit from this research.
What this research studies
This research investigates how well seasonal influenza and COVID-19 vaccines protect against acute illnesses that require outpatient care. By analyzing real-world data from patients in Central Texas, the study aims to provide accurate estimates of vaccine effectiveness over time. The research will focus on lab-confirmed cases of influenza and COVID-19, assessing how well the vaccines perform in preventing these infections. This information is crucial for public health efforts and for informing vaccination strategies.
Why it matters
Potential benefit: If successful, this research could lead to improved vaccination strategies that better protect patients from respiratory illnesses.
How similar studies have gone: Previous research has shown success in evaluating vaccine effectiveness, making this approach both relevant and necessary.
Where this research is happening
-
Baylor Research Institute
Dallas, United States Active
Researchers
- Principal investigator: Gaglani, Manjusha — Baylor Research Institute
- Study coordinator: Gaglani, Manjusha
Related research
Other NIH-funded projects on the same topics.
-
Motivational interviewing to increase COVID-19 and flu vaccination
This project teaches primary care providers conversational skills to help more adults, especially those in vulnerable communities, feel comfortable getting COVID-19 and flu shots.
-
Platform to Measure How Well Flu and COVID-19 Vaccines Work in Underserved Arizona Communities
A research effort in Arizona will track how well flu and COVID-19 vaccines protect people in underserved communities, including diverse adults and immunocompromised individuals.
-
Credible vaccine protection measures for Flu, COVID-19, and other respiratory viruses in Texas ambulatory care
This project looks at how well flu and COVID-19 vaccines protect people from visiting clinics for acute respiratory illnesses in Central Texas.
-
Platform to Measure How Well Seasonal Flu, COVID-19, and Other Respiratory Vaccines Prevent Illness in Real-Life Settings
This grant supports a national effort to track how well respiratory vaccines work in everyday clinics and homes.
-
Vaccine effectiveness in Michigan: how well flu, COVID-19 and other respiratory vaccines work
This project tests how well vaccines against flu, COVID-19, and other respiratory viruses prevent medically attended illness in people visiting outpatient clinics in Southeastern Michigan.
-
How well flu, COVID-19, and other respiratory vaccines protect people in southeastern Michigan
This project checks how well seasonal flu, COVID-19, and other respiratory vaccines protect people who visit clinics for coughs, colds, or breathing problems in southeastern Michigan.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.